MRC1 and neoplasm: As expected, LPS/IFN-γ treatment increased HLA-DR+CD80+ (p = 0.040) expression in macrophages (anti-tumor macrophages) and M-CSF induced CD206+CD163+ (p = 0.0082) macrophages (immunosuppressive macrophages) (Figure 5B).